Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:58:13 EDT Tue 09 Jun 2026
Enter Symbol
or Name
USA
CA



Q:INO - INOVIO PHARMACEUTICALS INC - https://www.inovio.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
INO - Q0.31.09·3.006.51.09+0.021.91,436.11,4472,9571.095  1.11  1.072.9789  1.0319:50:29May 2815 min RT 2¢

Recent Trades - Last 10 of 2957
Time ETExPriceChangeVolume
19:50:29Q1.120.05400
19:49:35Q1.11860.048630
19:22:31Q1.11990.04995
19:21:49Q1.100.031
19:21:19Q1.11840.04845
19:21:15Q1.120.0535
19:17:00Q1.11950.04951,000
19:08:16Q1.120.0510
18:54:46Q1.120.05200
18:37:27Q1.100.031

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-28 08:05U:INONews ReleaseINOVIO to Participate in Upcoming Scientific and Investor Conferences
2026-05-21 16:05U:INONews ReleasePositive Topline Results from a Phase 3 Trial for VGX-3100 in Cervical Dysplasia Patients Announced by ApolloBio, INOVIO's Partner in China
2026-05-13 16:05U:INONews ReleaseINOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
2026-05-08 08:05U:INONews ReleaseINOVIO to Participate in Upcoming Scientific Conferences
2026-05-01 16:05U:INONews ReleaseINOVIO to Report First Quarter Financial Results on May 13, 2026
2026-04-02 08:55U:INONews ReleaseINOVIO Announces Pricing of $17.5 Million Public Offering
2026-04-01 20:05U:INONews ReleaseINOVIO Announces Proposed Public Offering
2026-04-01 08:05U:INONews ReleaseINOVIO to Participate in Upcoming Scientific Conference
2026-03-12 16:05U:INONews ReleaseINOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
2026-03-09 08:05U:INONews ReleaseINOVIO to Participate in Upcoming Scientific Conferences
2026-03-05 16:05U:INONews ReleaseINOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
2026-03-04 08:05U:INONews ReleaseINOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
2026-02-12 08:05U:INONews ReleaseINOVIO to Participate in Upcoming Scientific and Investor Conferences
2026-02-10 20:36U:INONews ReleaseIINO Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against Inovio Pharmaceuticals, Inc.
2025-12-29 08:05U:INONews ReleaseFDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
2025-12-19 16:05U:INONews ReleaseINOVIO Reports Inducement Grant Under Inducement Plan
2025-11-18 08:05U:INONews ReleaseINOVIO to Participate in December Investor Conferences
2025-11-11 08:40U:INONews ReleaseINOVIO Announces Pricing of $25 Million Public Offering
2025-11-10 18:09U:INONews ReleaseINOVIO Announces Proposed Public Offering
2025-11-10 16:05U:INONews ReleaseINOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights